← Leaderboards
Eric P Hoffman
Reveragen Biopharma, Inc.
$47,884,792
Attributed
$51,979,615
Total exposure
53
Grants
34
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.9M · FY2005–24$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$64,373,312 · 54
FDA$1,201,236 · 1
By mechanism
R01$16,781,216 · 6
P50$11,188,992 · 5
U54$9,144,703 · 4
R24$7,674,088 · 1
R44$6,100,837 · 1
U01$3,519,267 · 1
Top collaborators
- Paula R Clemens7 shared
- Mary C. Rose3 shared
- Lauren M. Pachman1 shared
Others in their field
Top investigators on “Research Personnel”
- David Heimbrook · Leidos Biomedical Research, Inc.$701,463,488
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Leonard Freedman · Leidos Biomedical Research, Inc.$557,978,666
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David R. Weir · University Of Michigan At Ann Arbor$364,053,504
- Judith S. Currier · University Of California Los Angeles$284,675,012
Research focus
Research PersonnelGeneticChildBaseMolecularProteinsClinical ResearchFundingMuscleMuscular DystrophiesUnited States National Institutes Of HealthMutationProgramsLaboratoriesResourcesPharmaceutical PreparationsBiopsyBioinformaticsGenesClinical TrialsExonsAreaInnovationPhenotype
Grant awards (155)
Vamorolone trial in Becker muscular dystrophy$601,151
R01 · FY2024 · FD · contact PI
Clinical Trial Readiness for Monitoring Muscle Inflammation in Duchenne Muscular Dystrophy$192,285
R21 · FY2024 · TR · contact PI
Clinical Trial Readiness for Monitoring Muscle Inflammation in Duchenne Muscular Dystrophy$237,360
R21 · FY2023 · TR · contact PI
Commercialization Readiness Pilot (CRP) to maximize vamorolone international labeling and sales$1,672,364
SB1 · FY2021 · NS · contact PI
Vamorolone trial in Becker muscular dystrophy$600,085
R01 · FY2021 · FD · contact PI
Commercialization Readiness Pilot (CRP) to maximize vamorolone international labeling and sales$1,680,179
SB1 · FY2020 · NS · contact PI
Genomics_and_Proteomic-Core$173,761
U54 · FY2020 · HD · contact PI
Pivotal trial of vamorolone in Duchenne muscular dystrophy$1,499,060
R44 · FY2019 · NS · contact PI
Genomics_and_Proteomic-Core$167,829
U54 · FY2019 · HD · contact PI
Establishing a Cost-effective Return of Results to Parents of Boys in VISION-DMD Clinical Trials$109,999
R44 · FY2019 · NS · contact PI
Pivotal trial of vamorolone in Duchenne muscular dystrophy$1,500,000
R44 · FY2018 · NS · contact PI
Definition of pharmacodynamic biomarkers for juvenile dermatomyositis for clinical trials$225,000
R43 · FY2018 · AR · contact PI
Genomics_and_Proteomic-Core$124,781
U54 · FY2018 · HD · contact PI
Phase IIa study of VBP15 for Duchenne muscular dystrophy$1,496,525
R44 · FY2017 · NS · contact PI
Genomics_and_Proteomic-Core$167,019
U54 · FY2017 · HD · contact PI
Phase IIa study of VBP15 for Duchenne muscular dystrophy$1,495,253
R44 · FY2016 · NS · contact PI
Genomics_and_Proteomic-Core$199,531
U54 · FY2016 · HD · contact PI
Improved Diagnostic of the Muscular Dystrophies$415,360
R01 · FY2015 · NS · contact PI
RNA fidelity and protein function of Becker-like in-frame deletions$410,613
P50 · FY2015 · AR · contact PI
In vitro and in vivo functional assays$301,579
P50 · FY2015 · AR · contact PI
K12 Career Development Program: Omics of Pediatric Lung Diseases in DC$268,910
K12 · FY2015 · HL · contact PI
Optimization of AO drugs 45, 51 & 53$228,761
P50 · FY2015 · AR · contact PI
Molecular diagnostics and cell banking$211,388
P50 · FY2015 · AR · contact PI
Biomarker discovery for AO accumulation in kidney$98,422
U54 · FY2015 · HD · contact PI
Center for Research Translation of Systemic Exon-skipping in Muscular Dystrophy$1,542,768
P50 · FY2014 · AR · contact PI
Improved Diagnostic of the Muscular Dystrophies$569,861
R01 · FY2014 · NS · contact PI
RNA fidelity and protein function of Becker-like in-frame deletions$408,962
P50 · FY2014 · AR · contact PI
In vitro and in vivo functional assays$303,044
P50 · FY2014 · AR · contact PI
K12 Career Development Program: Omics of Pediatric Lung Diseases in DC$269,463
K12 · FY2014 · HL · contact PI
Optimization of AO drugs 45, 51 & 53$228,342
P50 · FY2014 · AR · contact PI
Molecular diagnostics and cell banking$212,236
P50 · FY2014 · AR · contact PI
Biomarker discovery for AO accumulation in kidney$99,955
U54 · FY2014 · HD · contact PI
Center for Research Translation of Systemic Exon-skipping in Muscular Dystrophy$1,469,599
P50 · FY2013 · AR · contact PI
NCMRR-DC Core Molecular & Functional Outcome Measures in Rehabilitation Medicine$870,953
R24 · FY2013 · HD · contact PI
Improved Diagnostic of the Muscular Dystrophies$457,965
R01 · FY2013 · NS · contact PI
RNA fidelity and protein function of Becker-like in-frame deletions$294,710
P50 · FY2013 · AR · contact PI
Optimization of AO drugs 45, 51 & 53$293,972
P50 · FY2013 · AR · contact PI
Molecular diagnostics and cell banking$268,717
P50 · FY2013 · AR · contact PI
In vitro and in vivo functional assays$236,122
P50 · FY2013 · AR · contact PI
K12 Career Development Program: Omics of Pediatric Lung Diseases in DC$124,200
K12 · FY2013 · HL · contact PI
Biomarker discovery for AO accumulation in kidney$101,699
U54 · FY2013 · HD · contact PI
A Prospective Study of the Urine Microbiome After Spinal Cord Injury$68,091
R24 · FY2013 · HD · contact PI
Center for Research Translation of Systemic Exon-skipping in Muscular Dystrophy$1,570,974
P50 · FY2012 · AR · contact PI
NCMRR-DC Core Molecular & Functional Outcome Measures in Rehabilitation Medicine$923,220
R24 · FY2012 · HD · contact PI
Improved Diagnostic of the Muscular Dystrophies$525,393
R01 · FY2012 · NS · contact PI
Genetics and Genomic Approaches to Lung Diseases and Disorders in Washington, DC$399,600
K12 · FY2012 · HL · contact PI
RNA fidelity and protein function of Becker-like in-frame deletions$390,469
P50 · FY2012 · AR · contact PI
In vitro and in vivo functional assays$294,991
P50 · FY2012 · AR · contact PI
Molecular diagnostics and cell banking$248,413
P50 · FY2012 · AR · contact PI
Optimization of AO drugs 45, 51 & 53$222,306
P50 · FY2012 · AR · contact PI
Biomarker discovery for AO accumulation in kidney$111,404
U54 · FY2012 · HD · contact PI
Center for Research Translation of Systemic Exon-skipping in Muscular Dystrophy$1,674,363
P50 · FY2011 · AR · contact PI
NCMRR-DC Core Molecular & Functional Outcome Measures in Rehabilitation Medicine$942,321
R24 · FY2011 · HD · contact PI
Improved Diagnostic of the Muscular Dystrophies$456,206
R01 · FY2011 · NS · contact PI
RNA fidelity and protein function of Becker-like in-frame deletions$376,663
P50 · FY2011 · AR · contact PI
GENETIC RISK FACTORS FOR METABOLIC SYNDROME IN MINORITY POPULATIONS$345,893
P20 · FY2011 · MD · contact PI
Genomics and Proteomics Core$257,482
P30 · FY2011 · HD · contact PI
Biomarker discovery for AO accumulation in kidney$116,334
U54 · FY2011 · HD · contact PI
NCMRR-DC Core Molecular & Functional Outcome Measures in Rehabilitation Medicine$973,339
R24 · FY2010 · HD · contact PI
Functional SNPs Associated with Human Muscle Size and Strength$771,359
R01 · FY2010 · AR · contact PI
Genetics and Genomic Approaches to Lung Diseases and Disorders in Washington, DC$399,600
K12 · FY2010 · HL · contact PI
GENETIC RISK FACTORS FOR METABOLIC SYNDROME IN MINORITY POPULATIONS$349,235
P20 · FY2010 · MD · contact PI
MOLECULAR GENETICS, PROTEOMICS AND BIOCHEMICAL ANALYSIS CORE$218,774
P30 · FY2010 · HD · contact PI
ASSESSING INHERITED MARKERS OF METABOLIC SYNDROME$86,607
M01 · FY2010 · RR · contact PI
AN EXERCISE INTERVENTION IN INSULIN-RESISTANT MINORITY ADOLESCENTS$11,743
M01 · FY2010 · RR · contact PI
Integrated Molecular Core for Rehabilitation Medicine$10,664
R24 · FY2010 · HD · contact PI
Wellstone Muscular Dystrophy Center: Children's Nat'l Med Ctr$1,340,177
U54 · FY2009 · HD · contact PI
Functional SNPs Associated with Human Muscle Size and Strength$775,484
R01 · FY2009 · AR · contact PI
Integrated Molecular Core for Rehabilitation Medicine$703,224
R24 · FY2009 · HD · contact PI
Improved Diagnostic of the Muscular Dystrophies$528,642
R01 · FY2009 · NS · contact PI
Genetics and Genomic Approaches to Lung Diseases and Disorders in Washington, DC$399,600
K12 · FY2009 · HL · contact PI
GENETIC RISK FACTORS FOR METABOLIC SYNDROME IN MINORITY POPULATIONS$347,091
P20 · FY2009 · MD · contact PI
Integrated Molecular Core for Rehabilitation Medicine$345,846
R24 · FY2009 · HD · contact PI
GENETIC MODIFIERS OF DUCHENNE MUSCULAR DYSTROPHY$223,364
U54 · FY2009 · HD · contact PI
MOLECULAR GENETICS, PROTEOMICS AND BIOCHEMICAL ANALYSIS CORE$215,741
P30 · FY2009 · HD · contact PI
AN EXERCISE INTERVENTION IN INSULIN-RESISTANT MINORITY ADOLESCENTS$15,749
M01 · FY2009 · RR · contact PI
Integrated Molecular Core for Rehabilitation Medicine$10,664
R24 · FY2009 · HD · contact PI
Wellstone Muscular Dystrophy Center: Children's Nat'l Med Ctr$10,664
U54 · FY2009 · HD · contact PI
ASSESSING INHERITED MARKERS OF METABOLIC SYNDROME$2,625
M01 · FY2009 · RR · contact PI
Wellstone Muscular Dystrophy Center: Children's Nat'l Med Ctr$1,340,249
U54 · FY2008 · HD · contact PI
Integrated Molecular Core for Rehabilitation Medicine$708,243
R24 · FY2008 · HD · contact PI
Functional SNPs Associated with Human Muscle Size and Strength$682,714
R01 · FY2008 · AR · contact PI
Improved Diagnostic of the Muscular Dystrophies$538,241
R01 · FY2008 · NS · contact PI
Genetics and Genomic Approaches to Lung Diseases and Disorders in Washington, DC$399,600
K12 · FY2008 · HL · contact PI
GENETIC RISK FACTORS FOR METABOLIC SYNDROME IN MINORITY POPULATIONS$297,329
P20 · FY2008 · MD · contact PI
MOLECULAR GENETICS, PROTEOMICS AND BIOCHEMICAL ANALYSIS CORE$224,385
P30 · FY2008 · HD · contact PI
GENETIC MODIFIERS OF DUCHENNE MUSCULAR DYSTROPHY$223,375
U54 · FY2008 · HD · contact PI
Functional SNPs Associated with Human Muscle Size and Strength$85,213
R01 · FY2008 · AR · contact PI
AN EXERCISE INTERVENTION IN INSULIN-RESISTANT MINORITY ADOLESCENTS$45,864
M01 · FY2008 · RR · contact PI
TYPE 2 DIABETES IN AFRICAN-AMERICAN CHILDREN: EXERCISE/INSULIN-RELATED MUSCLE SN$12,322
M01 · FY2008 · RR · contact PI
Wellstone Muscular Dystrophy Center: Children's Nat'l Med Ctr$6,000
U54 · FY2008 · HD · contact PI
CANDIDATE GENE AND PROTEIN STUDIES IN DISEASE$2,738
M01 · FY2008 · RR · contact PI
Wellstone Muscular Dystrophy Center: Children's Nat'l Med Ctr$1,540,856
U54 · FY2007 · HD · contact PI
Functional SNPs Associated with Human Muscle Size and Strength$714,583
R01 · FY2007 · AR · contact PI
Integrated Molecular Core for Rehabilitation Medicine$708,441
R24 · FY2007 · HD · contact PI
Improved Diagnostic of the Muscular Dystrophies$559,206
R01 · FY2007 · NS · contact PI
Genetics and Genomic Approaches to Lung Diseases and Disorders in Washington, DC$399,600
K12 · FY2007 · HL · contact PI
GENETIC RISK FACTORS FOR METABOLIC SYNDROME IN MINORITY POPULATIONS$260,927
P20 · FY2007 · MD · contact PI
Wellstone Muscular Dystrophy Center: Children's Nat'l Med Ctr$166,000
U54 · FY2007 · HD · contact PI
AN EXERCISE INTERVENTION IN INSULIN-RESISTANT MINORITY ADOLESCENTS$21,294
M01 · FY2007 · RR · contact PI
Wellstone Muscular Dystrophy Center: Children's Nat'l Med Ctr$12,187
U54 · FY2007 · HD · contact PI
TYPE 2 DIABETES IN AFRICAN-AMERICAN CHILDREN: EXERCISE/INSULIN-RELATED MUSCLE SN$5,721
M01 · FY2007 · RR · contact PI
CANDIDATE GENE AND PROTEIN STUDIES IN DISEASE$1,271
M01 · FY2007 · RR · contact PI
Wellstone Muscular Dystrophy Center: Children's Nat'l Med Ctr$1,408,908
U54 · FY2006 · HD · contact PI
Integrated Molecular Core for Rehabilitation Medicine$703,547
R24 · FY2006 · HD · contact PI
Improved Diagnostic of the Muscular Dystorphies$583,532
R01 · FY2006 · NS · contact PI
Wellstone Muscular Dystrophy Center: Children's Nat'l Med Ctr$12,188
U54 · FY2006 · HD · contact PI
AN EXERCISE INTERVENTION IN INSULIN-RESISTANT MINORITY ADOLESCENTS$3,098
M01 · FY2006 · RR · contact PI
TYPE 2 DIABETES IN AFRICAN-AMERICAN CHILDREN: EXERCISE/INSULIN-RELATED MUSCLE SN$2,065
M01 · FY2006 · RR · contact PI
CANDIDATE GENE AND PROTEIN STUDIES IN DISEASE$2,065
M01 · FY2006 · RR · contact PI
GENOME SCREEN FOR NEUROFIBROMATOSIS TYPE 1 MODIFIER LOCI$1,549
M01 · FY2006 · RR · contact PI
Wellstone Muscular Dystrophy Center: Children's Nat'l Med Ctr$1,500,000
U54 · FY2005 · HD
Integrated Molecular Core for Rehabilitation Medicine$705,535
R24 · FY2005 · HD
Improved Diagnostic of the Muscular Dystrophies$614,915
R01 · FY2005 · NS
Contractures: Molecular Remodeling of MTJ and Muscle$164,000
R21 · FY2005 · HD
AN EXERCISE INTERVENTION IN INSULIN-RESISTANT MINORITY ADOLESCENTS$12,944
M01 · FY2005 · RR
TYPE 2 DIABETES IN AFRICAN-AMERICAN CHILD: EXERCISE/INSULIN-RELATED MUSCLE SNPS$9,707
M01 · FY2005 · RR
MOLECULAR ASSOCIATIONS WITH RECURRENT PREGNANCY LOSS$6,470
M01 · FY2005 · RR
MONOCYTE MEMBRANE FUNCTION IN DYSFERLIN DEFICIENCY$1,616
M01 · FY2005 · RR
Functional SNP's Assoc with Human Muscle Size &Strength$1,161,817
R01 · FY2004 · NS
Contractures: Molecular Remodeling of MTJ and Muscle$164,000
R21 · FY2004 · HD
Image and Model Based Analysis of Lung Disease$9,107
M01 · FY2004 · RR
Synergistic CT-Bronchoscopy for Lung-Cancer Assessment$7,420
M01 · FY2004 · RR
Monocyte Membrane Function in Dysferlin Deficiency$5,262
M01 · FY2004 · RR
Gene expression profiling in individuals and families w$2,807
M01 · FY2004 · RR
Candidate Gene and Protein Studies in Disease$1,754
M01 · FY2004 · RR
Adenocarcinoma Expression Profiling Meta-analysis Identifies Molecular Sub-clas$1,063
P41 · FY2004 · RR
Functional SNP's Assoc with Human Muscle Size &Strength$1,136,135
R01 · FY2003 · NS
A FUNCTIONAL GENOMICS HEART &LUNG DEVELOP. PROGRAM$797,461
U01 · FY2003 · HL
IMPROVED DIAGNOSIS OF THE MUSCULAR DYSTROPHIES$310,075
R01 · FY2003 · NS
Contractures: Molecular Remodeling of MTJ and Muscle$164,000
R21 · FY2003 · HD
Integrated Standardized Express. Analytical Tools$164,000
R21 · FY2003 · HG
Functional SNP's Assoc with Human Muscle Size &Strength$1,110,923
R01 · FY2002 · NS
A FUNCTIONAL GENOMICS HEART &LUNG DEVELOP. PROGRAM$867,210
U01 · FY2002 · HL
IMPROVED DIAGNOSIS OF THE MUSCULAR DYSTROPHIES$301,041
R01 · FY2002 · NS
MOLECULAR GENETIC STUDIES OF RECURRENT PREGNANCY LOSS$269,981
R01 · FY2002 · HD
DEVELOPMENT OF TARGETING LIGANDS FOR DELIVERY TO MUSCLE$196,218
P01 · FY2002 · AR
MOLECULAR BASIS FOR HUMAN NEUROMUSCULAR DISEASE$0
P41 · FY2002 · RR
MOLECULAR BASIS FOR HUMAN NEUROMUSCULAR DISEASE$0
P41 · FY2002 · RR
Functional SNP's Assoc with Human Muscle Size &Strength$1,268,822
R01 · FY2001 · NS
A FUNCTIONAL GENOMICS HEART &LUNG DEVELOP. PROGRAM$932,080
U01 · FY2001 · HL
IMPROVED DIAGNOSIS OF THE MUSCULAR DYSTROPHIES$292,272
R01 · FY2001 · NS
MOLECULAR GENETICS OF RETT SYNDROME$287,694
R01 · FY2001 · NS
MOLECULAR GENETIC STUDIES OF RECURRENT PREGNANCY LOSS$264,016
R01 · FY2001 · HD
MOLEC PATHOPHYS OF CLIN VARIATION IN SPINAL CORD DISEASE$244,200
R21 · FY2001 · NS
DEVELOPMENT OF TARGETING LIGANDS FOR DELIVERY TO MUSCLE$196,218
P01 · FY2001 · AR
MOLECULAR BASIS FOR HUMAN NEUROMUSCULAR DISEASE$0
P41 · FY2001 · RR
A FUNCTIONAL GENOMICS HEART &LUNG DEVELOP. PROGRAM$922,516
U01 · FY2000 · HL
IMPROVED DIAGNOSIS OF THE MUSCULAR DYSTROPHIES$283,759
R01 · FY2000 · NS
MOLECULAR GENETICS OF RETT SYNDROME$279,314
R01 · FY2000 · NS
MOLECULAR GENETIC STUDIES OF RECURRENT PREGNANCY LOSS$260,457
R01 · FY2000 · HD
MOLEC PATHOPHYS OF CLIN VARIATION IN SPINAL CORD DISEASE$244,200
R21 · FY2000 · NS
DEVELOPMENT OF TARGETING LIGANDS FOR DELIVERY TO MUSCLE$171,130
P01 · FY2000 · AR
MOLECULAR GENETICS OF RETT SYNDROME$50,000
R01 · FY2000 · NS
IMPROVED DIAGNOSIS OF THE MUSCULAR DYSTROPHIES$25,000
R01 · FY2000 · NS